captopril has been researched along with Cerebrovascular Disorders in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (32.14) | 18.7374 |
| 1990's | 18 (64.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, R; Kitamura, T; Mukai, K; Murata, M; Otsuki, M; Shimomura, I; Tamada, D | 1 |
| Ganten, D; Lang, RE; Marin-Grez, M; Rascher, W; Unger, T; Yukimura, T | 1 |
| Clauser, E; Felix, D; Schelling, P | 1 |
| Kawashima, K; Saito, K; Sokabe, H; Watanabe, TX | 2 |
| Paulson, OB; Strandgaard, S | 1 |
| MacLeod, AB; Smeda, JS; Vasdev, S | 1 |
| Amann, K; Bohlender, J; Drab, M; Ganten, D; Wagner, J; Wienen, W | 1 |
| Boissel, JP; Gueyffier, F | 1 |
| Gong, L; Liu, G; Liu, L; Staessen, JA; Wang, JG | 1 |
| Björck, JE; Dahlöf, B; de Faire, U; Hansson, L; Hedner, T; Karlberg, BE; Lanke, J; Lindholm, LH; Luomanmäki, K; Mörlin, C; Niklason, A; Niskanen, L; Wester, PO | 1 |
| Scheen, AJ | 2 |
| Lim, PO | 1 |
| Brown, J; Brown, MJ | 1 |
| Boissel, JP; Gueyffier, F; Plouin, PF | 1 |
| Chikugo, T; Morita, N; Ohta, Y; Okamoto, K; Shiokawa, H | 1 |
| Chikugo, T; Hamada, Y; Morita, N; Ohta, Y; Okamoto, K; Shiokawa, H | 1 |
| Hoffman, WE; Kochs, E; Miletich, DJ; Rabito, SF; Werner, C | 1 |
| Chander, P; Gutstein, WH; Itskovitz, HD; Levine, S; Stier, CT | 1 |
| Coutard, M; Osborne-Pellegrin, M | 1 |
| Andersen, AR; Paulson, OB; Pedersen, H; Vorstrup, S; Waldemar, G | 1 |
| Kawashima, K; Kimura, M; Kobayashi, Y; Sokabe, H; Watanabe, TX | 1 |
| Arabidze, GG; Bykov, AV; Elizarova, NA; Katsnel'son, LA; Nikol'skaia, VA | 1 |
| Ikeda, M; Ito, K; Minematsu, K; Omae, T; Tsuchiya, M; Yamaguchi, T | 1 |
| Britton, KE; Granowska, M; Horne, T; Nimmon, CC | 1 |
1 review(s) available for captopril and Cerebrovascular Disorders
| Article | Year |
|---|---|
Antihypertensive drugs and cerebral circulation.
Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Brain; Captopril; Cerebrovascular Disorders; Homeostasis; Humans | 1996 |
6 trial(s) available for captopril and Cerebrovascular Disorders
| Article | Year |
|---|---|
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Proteinuria; Visual Acuity; Weight Gain | 1998 |
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Treatment Outcome; Visual Acuity; Weight Gain | 1998 |
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Cerebrovascular Disorders; China; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nitrendipine; Placebo Effect; Sodium Chloride Symporter Inhibitors; Systole | 1998 |
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Cause of Death; Cerebrovascular Disorders; Confidence Intervals; Diuretics; Female; Follow-Up Studies; Heart Diseases; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Survival Rate | 1999 |
[Clinical study of the month. The CAPPP study: "The Captopril Prevention Project"].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Cerebrovascular Disorders; Diabetes Mellitus; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 1999 |
[Severe and malignant arterial hypertension: the optimal treatment].
Topics: Adolescent; Adult; Blood Pressure; Captopril; Cerebrovascular Disorders; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertension, Malignant; Male; Middle Aged | 1988 |
21 other study(ies) available for captopril and Cerebrovascular Disorders
| Article | Year |
|---|---|
Saline Infusion Test highly associated with the incidence of cardio- and cerebrovascular events in primary aldosteronism.
Topics: Aged; Captopril; Cardiovascular Diseases; Cerebrovascular Disorders; Diagnostic Tests, Routine; Female; Furosemide; Humans; Hyperaldosteronism; Incidence; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Assessment | 2017 |
SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
Topics: 3-Mercaptopropionic Acid; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cerebrovascular Disorders; Hypertension; Kallikreins; Male; Natriuresis; Potassium; Proline; Rats; Renin; Sulfhydryl Compounds; Thiazolidines | 1982 |
Regulation of angiotensinogen in the central nervous system.
Topics: Aging; Angiotensinogen; Angiotensins; Animals; Blood Pressure; Brain; Captopril; Cerebrovascular Disorders; Hypertension; Male; Rats; Rats, Inbred Strains | 1983 |
Effects of long-term treatments with captopril on blood pressure and renin activity in the stroke-prone spontaneously hypertensive rats.
Topics: Animals; Body Weight; Captopril; Cerebrovascular Disorders; Heart Rate; Hypertension, Malignant; Kidney; Male; Proline; Rats; Renin; Stimulation, Chemical | 1980 |
The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cerebral Hemorrhage; Cerebrovascular Disorders; Genetic Predisposition to Disease; Hypertension; Male; Rats; Rats, Inbred SHR | 1997 |
Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Captopril; Cerebrovascular Disorders; Gene Expression; Hypertension; Kidney; Losartan; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Telmisartan | 1998 |
Hypertension Optimal Treatment (HOT) trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Cerebrovascular Disorders; Databases as Topic; Felodipine; Humans; Hypertension; Placebo Effect; Regression Analysis | 1998 |
CAPPP trial. Captopril Prevention Project.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cerebrovascular Disorders; Humans; Hypertension | 1999 |
CAPPP trial. Captopril Prevention Project.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cerebrovascular Disorders; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Middle Aged | 1999 |
CAPPP trial. Captopril Prevention Project.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cerebrovascular Disorders; Diuretics; Humans; Hypertension | 1999 |
CAPPP trial. Captopril Prevention Project.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cerebrovascular Disorders; Humans; Hypertension | 1999 |
Chronic treatment with captopril, SQ29,852, hydralazine and a 33% fish meal diet in malignant stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Cerebrovascular Disorders; Fish Products; Hydralazine; Hypertension, Malignant; Life Expectancy; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1991 |
Therapy and prevention of hypertension of M-SHRSP.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cerebrovascular Disorders; Diet; Disease Models, Animal; Disease Susceptibility; Fish Flour; Hydralazine; Hypertension, Malignant; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1991 |
Captopril improves neurologic outcome from incomplete cerebral ischemia in rats.
Topics: Animals; Blood Pressure; Brain Ischemia; Captopril; Cerebrovascular Disorders; Male; Nervous System; Rats; Rats, Inbred Strains | 1991 |
Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect.
Topics: Administration, Oral; Animals; Blood Pressure; Brain; Captopril; Cerebrovascular Disorders; Enalapril; Heart; Hypertension; Hypotension; Kidney; Male; Myocardium; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Risk Factors; Sodium | 1991 |
Rupture of the internal elastic lamina and vascular fragility in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Arteries; Atenolol; Blood Pressure; Capillary Fragility; Captopril; Cerebrovascular Disorders; Hydralazine; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Mutant Strains; Renal Artery; Rupture, Spontaneous; Vascular Diseases | 1991 |
Angiotensin-converting enzyme inhibition and regional cerebral blood flow in acute stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Tomography, Emission-Computed; Xenon Radioisotopes | 1989 |
Effects of enalapril and captopril on urinary excretion of kinins and electrolytes in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Captopril; Cerebrovascular Disorders; Electrolytes; Enalapril; Hypertension; Kinins; Male; Potassium; Rats; Rats, Inbred SHR; Sodium; Time Factors | 1985 |
Prevention of renal damage and decrease of urinary kinins excretion by chronic treatments with enalapril and captopril in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Captopril; Cerebrovascular Disorders; Enalapril; Hypertension, Renal; Kidney Diseases; Kinins; Male; Rats; Rats, Inbred SHR | 1987 |
Effect of angiotensin converting enzyme inhibitor (captopril) on cerebral blood flow in hypertensive patients without a history of stroke.
Topics: Adult; Aged; Blood Pressure; Captopril; Carbon Dioxide; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Hypertension; Male; Middle Aged | 1987 |
Cerebral blood flow in hypertensive patients with cerebrovascular disease: technique for measurement and effect of captopril.
Topics: Adult; Captopril; Cerebrovascular Circulation; Cerebrovascular Disorders; Erythrocytes; Humans; Hypertension; Male; Proline; Technetium | 1985 |